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Clinicalevidence indicatesthatelectroacupuncture (EA) iseﬀective forallergic disorder.Recent animalstudies haveshownthatEA
treatment reduces levels of IgE and Th2 cytokines in BALB/c mice immunized with 2,4-dinitrophenylated keyhole limpet protein
(DNP-KLH). The hypothalamus, a brain center of the neural-immune system, is known to be activated by EA stimulation. This
study was performed to identify and characterize the diﬀerentially expressed genes in the hypothalamus of DNP-KLH immunized
mice that were stimulated with EA or only restrained. To this aim, we conducted a microarray analysis to evaluate the global
gene expression proﬁles, using the hypothalamic RNA samples taken from three groups of mice: (i) normal control group (no
treatments); (ii) IMH group (DNP-KLH immunization + restraint); and (iii) IMEA group (immunization + EA stimulation).
The microarray analysis revealed that total 39 genes were altered in their expression levels by EA treatment. Ten genes, including
T-cell receptor alpha variable region family13 subfamily 1 (Tcra-V13.1),heat shockprotein 1B (Hspa1b) and2 –5  oligoadenylate
synthetase1F(Oas1f),wereup-regulated intheIMEA group whencomparedwith theIMH group. In contrast,29genes, including
decay accelerating factor 2 (Daf2),NAD(P)H dehydrogenase, quinone1 (Nqo1) andprogrammed cell death 1ligand 2(Pdcd1lg2)
were down-regulated in the IMEA group as compared with the IMH group. These results suggest that EA treatment can modulate
immune response in DNP-KLH immunized mice by regulating expression levels of genes that are associated with innate immune,
cellular defense and/or other kinds of immune system in the hypothalamus.
1.Introduction
Several clinical studies have previously suggested that elec-
troacupuncture (EA) is eﬀective for the treatment of various
types of allergic disorders, including asthma and chronic
urticaria [1–4]. It is generally accepted that hyperproduction
of IgE in response to stimulation by Th2 cytokines (i.e.,
IL-4, IL-5 and IL-13) promotes the development of these
allergic disorders [5, 6] .O u rp r e v i o u ss t u d yd e m o n s t r a t e d
that successive EA at the ST36 acupoint reduces serum levels
of IgE in BALB/c mice that have been immunized with
2,4-dinitrophenylated keyhole limpet protein (DNP-KLH)
via suppression of the production of Th2 cytokines [7].
Furthermore, it has been shown that these eﬀects of EA are
mediated, at least in part, by α-adrenergic receptors [8]a n d
are acupoint (ST36) speciﬁc [9].
The hypothalamus is the primary center for neuroendo-
crine-immunemodulation[10].Theparaventricularnucleus
of the hypothalamus (PVN) represents an integral part of
the neuroendocrine circuit that modulates immune func-
tion. Moreover, stimulation of the ventral nucleus of the
hypothalamus (VMH) stimulation enhances the immune2 Evidence-Based Complementary and Alternative Medicine
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Figure 1:Comparisonofserum IgElevelsinthethree experimental
groups. The amounts of serum IgE were measured by ELISA.
Data are presented as the mean±SEM. ∗∗P < .01, ∗∗∗P < .001
between the two indicated groups as determined by the Newman-
Keuls multiple comparison test following one-way ANOVA. NC
(n=7, no treatments for 2 weeks, except for i.p. injection of saline
on the 1st and 8th experimental day); IMH (n=6, immunization
on the 1st and 8th experimental day + daily holder restraint);
IMEA (n=6, immunization on the 1st and 8th experimental
day+daily EA stimulation at the ST36 acupoint under holder
restraint).
function associated with the lateral hypothalamus (LH) and
ventral tegmental area (VTA) of the brain. Interestingly,
previous brain imaging studies of animals and humans have
shown that EA treatment aﬀects the neuronal activity of the
hypothalamus [11–16]. Although it has also been reported
that EA inﬂuences the immunomodulatory eﬀects of the
hypothalamus [17, 18], the studies that have been conducted
to date have only investigated the eﬀects of EA on normal
rats.
Oligonucleotidemicroarray analysisisthemost powerful
toolforfunctionalgenomicsthatprovidesdirectinformation
aboutmRNAexpression levelsfrom a large numberofgenes.
This method has been used to ﬁnd the genes correlated
with the pathogenesis of diseases and to assess the drug
actions on the diseases [19, 20]. To examine if and how
EA treatment modulates immune function of the hypotha-
lamus at transcriptional level in a Th2-skewed condition,
we conducted a microarray analysis on the hypothalamus
of DNP-KLH immunized mice that were stimulated with
EA.
2.Methods
2.1. Animals. Eight-week-old female BALB/c mice were pur-
chased from Orient Bio (Sungnam, Korea) and housed in
an air-controlled, pathogen-free animal facility under a 12-
h light/dark cycle at 23±2◦C. Mice were provided with a
standard laboratorydietand waterad libitum. Allprocedures
involving animals were conducted in accordance with the
NIH guidelines.
2.2. Experimental Groups. Mice were randomly divided into
the following 3 groups (n=6–10/group): (i) NC group (nor-
mal control, no treatments for 2 weeks, except for i.p.
injection of saline on the 1st and 8th experimental day);
(ii) IMH group (immunization with 2,4-dinitrophenylated
keyhole limpet protein (DNP-KLH) on the 1st and 8th
experimental day and being held in a holder restraint for 20
min a day for 2 weeks; (iii) IMEA group (immunization on
the 1st and 8th experimental day+daily EA stimulation at
the ST36 acupoint while being held in a holder restraint for
20min a day for 2 weeks).
2.3. EA Stimulation and DNP-KLH Immunization. EA stim-
ulation was performed as previously described [7]. Brieﬂy, a
pair of stainless steel needles (0.2mm in diameter and 3cm
long) was inserted into the ST36, which is located at the
anterior tibial muscle, 5mm laterally and lower from the
anterior tubercle of the tibia, and at a point 5mm distal
from the ﬁrst needle. The anode and cathode leads from
an electrical stimulator were then connected to the two
acupuncture needles, after which train-pulses (1Hz, 0.25ms
pulse width, 3–5V)were appliedfor20min. The stimulation
intensity was determined to be the minimum voltage that
induced a moderate muscle contraction.
All mice, except for the NC group, were immunized
intraperitoneally with4μgofDNP-KLH(Calbiochem,Gibb-
stown, NJ, USA) and 4mg of aluminum hydroxide (Sigma,
St Louis, MO, USA) on the 1st and 8th day during the 2-
week experimental period. Immunization of BALB/c mice
with DNP-KLH caused a signiﬁcant increase in IgE and
IL-4 production on the 14th day after ﬁrst immunization;
therefore, EA stimulation was conducted daily for 2 weeks
[7].
2.4. Measurements of IgE in Serum Using ELISA. Serum was
obtained from all groups of mice on the ﬁnal experimental
day and then stored at −20◦C until analysis. The Serum
level of IgE was measured using a quantitative sandwich
enzyme-linked immunoassay kit (BD, Franklin Lakes, NJ,
USA). Brieﬂy, a 96-well microtiter plate (Coster, Cambridge,
MA, USA) was incubated overnight at 4◦C with anti-
mouse IgE monoclonal antibody in coating buﬀer. The
plate was then washed with PBS containing 0.05% tween
20 (Sigma, USA) and blocked with 5% FBS in PBS for 1h
at room temperature. Subsequently, 100μlo fs a m p l ew e r e
loaded onto the plate, which was then incubated for 2h
at room temperature. Next, secondary peroxidase labeled
biotinylatedanti-mouse IgEmonoclonalantibodyin5%FBS
in PBS diluent was added and the plate was incubated for
an additional 1h. The plates were then treated with TMB
substrate solution for 30min, after which the reaction was
stopped by the addition 50μlo f2 NH 2SO4 stop solution per
well. Finally, the optical density at 450nm was measured in a
microplate reader (TECAN, Durham, NC, USA).
2.5. Oligonucleotide Chip Microarray. The hypothalamuses
were obtained from all groups of mice on the ﬁnal
experimental day and then stored at −80◦C until analysis.Evidence-Based Complementary and Alternative Medicine 3
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Figure 2: Clustergram of up- and down-regulated genes in DNP-KLH immunized BALB/c mice that were subjected to EA stimulation.
The results shown are representative of three independent samples collected for each treatment. Each gene is represented by a single row of
clustered boxes and each experimental sample is represented by a single column. The entire clustered image is shown on the left. The signal
averages of up- and down-regulated genes are shown on the right.
Total RNA was extracted from the hypothalamus by using
TRIZOL reagent, and DNase I (Invitrogen Life Technologies,
Rockville, MD, USA) was treated to eliminate genomic DNA
contamination. Oligonucleotide chip microarray was per-
formed using single round RNAampliﬁcation protocols, fol-
lowing the Aﬀymetrix speciﬁcations (Aﬀymetrix GeneChip
Expression Analysis Technical Manual). Brieﬂy, 3μgo ft o t a l
RNA was used to synthesize ﬁrst-strand complementary
DNA (cDNA) using oligonucleotide probes with 24 oligo-
dT plus T7 promoter as primers (Proligo LLC, Boulder, CO,
USA) and the Superscript Choice System (Life Technologies,
Invitrogen, Milan, Italy). Following double-stranded cDNA
synthesis, the products were puriﬁed by phenol-chloroform
extraction, afterwhichbiotinylated antisense complimentary
RNA (cRNA) was generated through in vitro transcription
using a BioArray RNA High-Yield Transcript Labeling Kit
(ENZO Life Sciences Inc., Farmingdale, NY, USA). Next,
the biotinylated labeled cRNA was fragmented, and then
10g of the total fragmented cRNA was hybridized to the
GeneChipMouseGene1.0STArray(P/N901178,Aﬀymetrix
Inc., Santa Clara, CA, USA). The Aﬀymetrix Fluidics Station
400 was then used to wash and stain the chips, after which
the nonhybridized target was removed. The samples were
then incubated with a streptavidin-phycoerythrin conju-
gate to stain the biotinylated cRNA. Next, the staining
was ampliﬁed using goat IgG as a blocking reagent and
biotinylated antistreptavidin antibody (goat), followed by
a second staining step using a streptavidin-phycoerythrin
conjugate. The ﬂuorescence was then detected using the
Genechip System Confocal Scanner (Hewlett-Packard, Santa
Clara, USA), and analysis of the data contained on each
GeneChip was conducted using the GeneChip 3.1 software
produced by Aﬀymetrix using the default settings. Global
scaling was then used to compare the chips, with all probe
sets being scaled to a user-deﬁned target intensity of 150.
2.6. Data Analysis. One-way ANOVA followed by Newman–
Keuls multiple comparison test was used for statistical
analysis of the IgE data. In all cases, P <.05 was considered
signiﬁcant. Data are presented as the mean±SEM.
For analysis of the microarray data, the MAS5 algorithm
was used to evaluate the expression signals generated by the
Aﬀymetrix Mouse Gene 1.0ST Array. Global scaling nor-
malization was then performed, after which the normalized
data were log-transformed using base 2. Next, a fold change4 Evidence-Based Complementary and Alternative Medicine
Table 1: Alterations in gene expression in DNP-KLH immunized BALB/c mice that were treated with EA stimulation.
Genes Symbol
Regulation proﬁle and average fold change
NC versus Hold Hold versus EA
<Cluster 3>
T-cell receptor alpha variable region family 13 subfamily 1 Tcra-V13.1 −0.35 0.88
Limb expression 1 homolog (chicken) Lix1 −0.11 0.3
Trefoil factor 2 (spasmolytic protein 1) Tﬀ2 −0.12 0.31
Heat shock protein 1B Hspa1b −0.08 0.38
Olfactory receptor 1436 Olfr1436 −0.23 0.55
Olfactory receptor 1475 Olfr1475 −0.43 1.15
2 –5  oligoadenylate synthetase 1F Oas1f −0.23 0.34
Olfactory receptor 689 Olfr689 −0.13 0.35
Olfactory receptor 26 Olfr26 −0.10 0.39
Probasin Pbsn −0.44 0.80
<Cluster 5>
Dermatopontin Dpt 0.15 −0.29
Decay accelerating factor 2 Daf2 0.17 −0.30
Anterior gradient homolog3 (Xenopus laevis) Agr3 0.13 −0.35
Secretagogin, EF-hand calcium binding protein Scgn 0.36 −0.35
3-oxoacyl-ACP synthase, mitochondrial Oxsm 0.22 −0.32
Empty spiracles homolog 2 (Drosophila) Emx2 0.48 −0.45
Aldehyde dehydrogenase 3 family, member B1 Aldh3b1 0.22 −0.38
Cytochrome P450, family 2, subfamily c, polypeptide 38 Cyp2c38 0.27 −0.79
Sulﬁde quinone reductase-like (yeast) Sqrdl 0.20 −0.28
Olfactory receptor 1231 Olfr1231 0.27 −0.35
Myosin light chain 2, precursor lymphocyte-speciﬁc Mylc2pl 0.13 −0.26
NLR family, pyrin domain containing 4E Nlrp4e 2.32 −3.96
Olfactory receptor 617 Olfr617 0.21 −0.37
Olfactory receptor 544 Olfr544 0.29 −0.37
Carboxylesterase 2 Ces2 0.09 −0.28
NAD(P)H dehydrogenase, quinone 1 Nqo1 0.17 −0.28
Sodium channel, voltage-gated, type X, alpha Scn10a 0.17 −0.45
<Cluster 6>
Olfactory receptor 1393 Olfr1393 −0.1 −0.47
Insulin-like growth factor 2 mRNA binding protein 1 Igf2bp1 0.05 −0.29
Cathepsin 3 Cts3 0.06 −0.39
Olfactory receptor 720 Olfr720 −0.19 −0.27
Cell division cycle 25 homologC (S. pombe) Cdc25c 0.05 −0.27
Programmed cell death 1 ligand 2 Pdcd1lg2 0.05 −0.34
Olfactory receptor 1310 Olfr1310 0.03 −0.55
Group speciﬁc component Gc −0.02 −0.32
G protein-coupled receptor, family C, group 5, member D Gprc5d −0.07 −0.37
Serum amyloid A 4 Saa4 −0.51 −0.53
Vomeronasal2, receptor 65 Vmn2r65 0.05 −0.53
Intestine speciﬁc homeobox Isx 0.05 −0.29
and a Welch t-test were applied to select the diﬀerentially
expressed genes (DEGs) using a fold change threshold of 1.2
and a P <.05 to indicate signiﬁcance. Each probe set used
in the Aﬀymetrix GeneChip produces a detection call, with
P (present call) indicating good quality, M (marginal call)
indicatingintermediatequalityandA(absentcall)indicating
relatively low reliability. Therefore, probe sets that resulted
in A calls were removed to ﬁlter false positives. A volcano
plot was used to better visualize and compare the two
DEG methods. The 1.2-fold DEGs were clustered using theEvidence-Based Complementary and Alternative Medicine 5
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Figure 3: Gene ontology assignment of DEGs. Bars on Cluster 3
indicate up-regulated genes and bars on Cluster 5 and Cluster 6
indicate down-regulated genes comparing IMEA with IMH.
GenPlexTM v2.3 software (ISTECH Inc., Ilsan, Korea) using
hierarchical clustering with Pearson correlation as a similar-
ity measure and complete linkage as the linkage method. In
addition, gene ontology signiﬁcance analysis was conducted
to investigate the functional relationships among the 1.2-
fold DEGs using high-throughput GoMiner. The 1.2-fold
DEGs were then mapped to the relevant pathways using
the GenPlex v2.4 software (ISTECH Inc., Ilsan, Korea). The
pathway resources were provided by the KEGG database.
3.Results
3.1. IgE Levels in DNP-KLH Immunized Mice Following EA
Stimulation. BALB/c mice were immunized with DNP-KLH
and aluminum hydroxide once a week. In the IMEA group,
20-min EA stimulation at the ST36 acupoint under restraint
with an acryl holder was performed daily for 2 weeks,
whereas mice in the IMH group were placed in the holder
Table 2: Categorized pathways based on comparison of gene
expression between IMH and IMEA groups.
KEGG Pathway Gene counts P-value
Metabolism of xenobiotics by
cytochrome P450 25 . 0 6 E−05
Fatty acid biosynthesis 1 1.18E−03
Biosynthesis of steroids 1 3.87E−03
Phenylalanine metabolism 1 5.22E−03
Histidine metabolism 1 5.89E−03
Cell cycle 1 5.95E−03
Neuroactive ligand-
receptor interaction 17 . 1 1 E−03
Linoleic acid metabolism 1 7.23E−03
Cell adhesion molecules (CAMs) 1 7.69E−03
Tyrosine metabolism 1 8.74E−03
Arachidonic acid metabolism 1 1.13E−02
Complement and coagulation cascades 1 1.18E−02
Hematopoietic cell lineage 1 1.34E−02
Glycolysis/Gluconeogenesis 1 1.38E−02
Leukocyte transendothelial migration 1 1.79E−02
Tight junction 1 2.17E−02
Focal adhesion 1 3.25E−02
Regulation of actin cytoskeleton 1 3.36E−02
restraint for 20min a day for 2 weeks, but not treated. After
the 2-week experimental period, the serum levels ofIgE were
measured. Figure 1 shows serum levels of IgE in mice. The
IgE levels in the IMH and the IMEA group were signiﬁcantly
increasedwhencomparedwiththeIgElevelsoftheNCgroup
(P <.001). However, EA treatment signiﬁcantly reduced the
elevated IgE levels (P <.01, IMEA versus IMH).
3.2. DEGs in the Hypothalamus of Mice in the NC, IMH and
IMEA Groups. The genes that were diﬀerentially expressed
among the groups are listed in Table 1 In addition, the genes
are grouped into functional categories and pathways based
on the KEGG database in Table 2. There were 10 genes that
were down-regulated in the IMH group (versus NC) and
up-regulated in the IMEA group (versus IMH). Conversely,
17 genes were up-regulated in the IMH group (versus NC)
a n dd o w n - r e g u l a t e di nt h eI M E Ag r o u p( v e r s u sI M H ) .
Additionally, 12 genes were not signiﬁcantly changed in the
IMH group (versus NC), but were down-regulated in the
IMEA group (versus IMH).
3.3. Clustering Analysis and Gene Ontology Analysis. As
s h o w ni nF i g u r e2, microarray data from the normal control
(NC) group and the experimental (IMH and IMEA) groups
were combined and clustered using hierarchical clustering.
To examine the functional relationships among the 1.2-
fold DEGs, the diﬀerence in gene ontology was determined
using signiﬁcance analysis (Figure 3). The results revealed
that genes that were up- and down-regulated in the exper-
imental groups were associated with processes including6 Evidence-Based Complementary and Alternative Medicine
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Figure 4: Summary of the mechanisms underlying EA-induced regulation of gene expression in the hypothalamus for anti-allergic eﬀects.
signal transduction, cellular defense response, transport,
transcription, biological processes, translation, the cell cycle
and T cell proliferation.
4.Discussion
DNP-KLH immunization is known to induce the elevation
of serum IgE levelsand Th2 cytokines, which play important
roles in the developmentof various allergic disorders [7, 21].
In the present study, BALB/c mice in the IMH and IMEA
groups were immunized with DNP-KLH and aluminum
hydroxide. Although both groups showed a signiﬁcant
increase in IgElevelswhen comparedwith the NCgroup,IgE
levels in the IMEA group were signiﬁcantly lower than those
intheIMHgroup(Figure1).Thisresultisconsistentwiththe
results of previous studies [7–9] and strongly suggests that
EA treatment can modulate the immune response in the Th2
dominant condition.
Microarray analysis has been shown to be useful for the
simultaneous proﬁling of global gene expression and identi-
ﬁcation of new genes or new functions of known genes [19,
20]. As described in the introduction, the hypothalamus is a
primary center in the central nervous system responsible for
neural-immune modulation [10] and has been shown to be
aﬀected by EA treatment [11, 12, 15]. Moreover, our recent
study [18] showed that EA stimulation at ST36 can alter
the transcriptional activity of the hypothalamus in normal
rats. Therefore, we conducted microarray analysis of the
hypothalamusofDNP-KLHimmunized micetodetermineif
EAtreatmentofmiceinaTh2-skewed conditioncanregulate
gene expression in the hypothalamus.
Ten genes, includingT-cell receptoralpha variable region
family 13 subfamily 1 (Tcra-V13.1), trefoil factor 2 (spas-
molytic protein 1) (Tﬀ2), heat shock protein 1B (Hspa1b)
and 2 –5  oligoadenylate synthetase 1F (Oas1f), were down-
regulated in the IMH group when compared with the NC
group and up-regulated in the IMEA group when compared
with the IMH group. Tcra-V13.1 is a subfamily of the T-
cell receptor Vα chain and contributes to the recognition
of self-MHC molecules or peptides that has polymorphisms
associated with diabetes [22, 23]. The expression pattern of
Tﬀ2, which is a member of the newly discovered protective
factor of gastrointestinal mucous, may be associated with
gastric cancer [24]. Hspa1b is involved in innate immunity
and diverse biological processes including anti-apoptosis,
response to stress and DNA repair [25, 26]. Oas1f is a
transcription unit of a family of interferon-induced antiviral
proteins that may play a role in the host’s innate defense
mechanism against viral infection [27, 28]. The diﬀerential
expression of these genes indicates that EA treatment may
increase some activities of innate immune and cellular
defense at the transcriptional level.
Conversely,17genesincludingdecayacceleratingfactor2
(Daf2), cytochrome P450, family 2, subfamily c, polypeptide
38 (Cyp2c38), myosin light chain 2, precursor lymphocyte-
speciﬁc (Mylc2pl), NAD(P)Hdehydrogenase, and quinone 1
(Nqo1)were up-regulatedin theIMHgroupwhen compared
with the NC group and downregulated in the IMEA group
when compared with the IMH group. In addition, 12 genes,
including programmed cell death 1 ligand 2 (Pdcd1lg2),
were downregulated in the IMEA group when compared
with the IMH group, but not signiﬁcantly changed in the
IMH group when compared with the NC group. Daf2 is
a glycosylphosphatidylinositol (GPI)-anchored membrane
regulator thatinhibits both theclassical and alternative path-
ways of complement activation [29]. Cyp2c38 is a member
of a superfamily of ubiquitoushemoproteinsthat metabolize
a vast array of foreign chemicals as well as endogenous
compounds [30]. Mylc2pl is a regulatory myosin light chain
gene that is expressed speciﬁcally in precursor B and T
lymphocytes and may play a role in lymphocyte develop-
ment [31]. Nqo1 is a cytosolic enzyme that catalyzes the
metabolic reduction of quinines and derivatives and is an
endogenousfactorintheregulationofimmuneresponse and
autoimmunity [32]. Pdcd1lg2 is a ligand for programmed
cell death-1, which is a receptor that plays an inhibitory role
in T cell activation and has a potential role in Th2-mediated
diseases [33]. As shown in Table 2 and Figure 3, it appearsEvidence-Based Complementary and Alternative Medicine 7
t h a tn om a j o ro rs p e c i ﬁ cb i o c h e m i c a lp a t h w a y sa r er e g u l a t e d
by EA treatment. However, the present data suggest that EA
treatment widely regulates immune response in the hypo-
thalamus at the transcriptional level.
In conclusion, EA treatment was found to reduce the
serum levels of IgE that were elevated by DNP-KLH immu-
nization in BALB/c mice. Furthermore, EA treatment altered
the expression levels of 39 genes in the hypothalamus, many
of which are involved in immune response (Figure 4). Taken
together, these results suggest that EA treatment may induce
immunomodulation by regulating gene expressions in the
hypothalamus of DNP-KLH immunized mice.
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